DELPHINIUM is a dedicated and dynamic company, comprised of experienced professionals committed to Phase I clinical pharmacology. Our 12-bed Phase I clinic specializes in studies conducted with healthy volunteers, offering a range of services including Monitoring, Project Management, Data Management, Bioanalysis and more.
Our mission is to deliver high-quality, tailor-made Phase I clinical research in which we prioritize efficient and direct communication between Sponsors and researchers to ensure a flexible, fast, and adaptive approach to your clinical program. We believe that the synergy of experience, commitment, and a personalized approach will result in the highest quality output for Sponsors and a safe and comfortable environment for our volunteers.
Please contact us at info@delphiniumcro.com to discuss our services and how we can assist you in advancing your clinical trial.
Company Details
- Employees
- 12
- Founded
- 2024
- Address
- Groningen, Groningen, Nl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.delphiniumcro.com
- Keywords
- Phase 1 Clinical Research.
- HQ
- Groningen, Groningen
Delphinium Questions
Delphinium's website is https://www.delphiniumcro.com
Delphinium's LinkedIn profile is https://nl.linkedin.com/company/delphiniumcro
Delphinium has
12 employees.
View email and phone details for 12
employees at Delphinium.
Delphinium's industry is
Biotechnology Research
Delphinium's top competitors are
Qps Holdings, Llc,
Ardena,
Ctc Clinical Trial Consultants Ab,
Tracer,
Research Drive Bv,
Qps Netherlands B.v.,
Ctc Netherlands,
Next Oncology,
Veramed,
Axon Medchem.
Delphinium's categories are Biotechnology Research
Delphinium's founding year is 2024
